Sharepoint Solutions
PRODUCTS
-
Seamlessly integrated with Curebase’s ePRO/eCOA suite, our EDC enables hybrid and site-based studies that users will love and that streamline all of your data collection into a single, modern experience.
-
The TWIST™ Mini Liposome Extruder System is an all-inclusive modular liposome extrusion system. The intuitive design allows novice and expert users the ability to create liposome particles ranging from 50 nm to 10 um in diameter. With the heat block and extruder base, users have extended liposome creation capabilities and an easy, ergonomic set up. The TWIST™ System is the perfect solution for small scale R&D and liposome exploration projects.
-
Used Kikusui tablet in tablet press, model Aquarius G-J/DC, 36 station, keyed upper punch guides, B tooled, 100 kN pre-compression, 100 kN main compression, 16mm max tablet diameter, 18mm max depth of fill, rated up to 259,200 tablets/hour, with DC module for core feeder, 4-15mm core depth adjustment, with integrated primary and secondary powder feed hoppers, and core feed hopper, project# 1-6302, built 2009.
-
Electronic informed consent for patient-centric decentralized clinical trials.
-
Code and approve clinical trial data from any device and keep your safety and efficacy data clean, consistent, and ready for analysis.
WHITE PAPERS AND CASE STUDIES
-
Can Your Biopharma Team Keep Unplanned Downtime At Bay?
Learn how teams reduce downtime, strengthen compliance, and respond quickly to equipment issues through proactive maintenance, smart spare parts planning, and digital troubleshooting tools.
-
Partnering For Precision In An IPF Study: Securing Timely Deliverables And Key Endpoints
A pharmaceutical company enlisted Worldwide Clinical Trials to help achieve on-time results for their Phase IIa IPF clinical trial, enabling them to manage vendors and meet challenging deadlines.
-
Manufacturing Transfers: Delivering 140+ Precision Medical Devices Without Missing A Deadline
Go inside a successful manufacturing transfer of over 140 Class-III silicone medical devices and on-time delivery for a top-30 OEM through expert project management and rigorous validation processes.
-
Authentic Engagement: Reaching Underserved Lupus Patients
By partnering with the ICLF, see how we were able to gain access to and build trust with influential community leaders and advocates within the African American communities located near study sites.
-
Navigating Digital Transformation For Pharmaceutical CDMOs
Discover how CDMOs can modernize operations, safeguard data integrity, and improve audit readiness with practical strategies for connecting systems and reducing validation burdens.
-
Comprehensive Pathway To Seamless Scale-Up Of mRNA DP Manufacturing
An integrated approach to mRNA drug product manufacturing helps to accelerate drug development, mitigate risks, and ultimately deliver life-changing therapies to patients.
-
The EMR Interoperability Dream Vs. Clinical Research Reality
Seamless Electronic Medical Record access promises accelerated trials and regulatory-grade evidence, but incomplete, unstructured data requires hybrid strategies using AI and human oversight to bridge gaps.
-
History Of Peptides In Medicine: From Early Chemistry To The GLP-1 Era
Peptide therapeutics from early chemical breakthroughs to today’s metabolic drugs, highlighting scientific, clinical, and manufacturing advances shaping modern drug development.
-
Project Orbis Drug Registration 2025
Project Orbis helps streamline the review and approval of oncology medicinal products through international regulatory collaboration. Learn how this framework can accelerate your regulatory strategy.
-
Clinical Trial Starts Rose At Slower Pace In 2024
Clinical trial starts grew 5.5% to 10,503 in 2024, a slowdown from 2023’s 9.4% rise in trial starts. Sustained geopolitical and global regulatory pressures on pharma contributed to curbing momentum.
-
Relieving The Strain Of Publishing During Regulatory Registration
Go inside how an expertly handled NDA submission for a biopharma company ensured timely FDA approval despite challenges.
-
Soil Testing: From Filtration To Fertilizer To Food
Soil analysis offers a clear view of the factors that influence land productivity while helping identify contaminants that could threaten safety. Understand the indicators to support sustainability decisions.
NEWS
-
PolyPeptide Strengthens Global Peptide Production With Modular Facility Design Approach9/24/2025
PolyPeptide Group AG (SIX: PPGN), a specialized, global CDMO for peptide-based active pharmaceutical ingredients, today announced the successful delivery and installation of pre-built modules at its Malmö, Sweden facility. This marks a key milestone in the company’s modular expansion project at the site, which aims to double its solid-phase peptide synthesis (SPPS) capacity.
-
WRF Seeks Pre-Proposals For High-Priority Utility Research1/15/2026
The Water Research Foundation (WRF) is now accepting pre-proposals for its matching research program, the Tailored Collaboration Program.
-
Danforth Center Awards Proof-Of-Concept Funding To Four Scientific Teams Advancing Agricultural Innovation8/18/2025
As part of its Startup Initiative, the Donald Danforth Plant Science Center has awarded proof-of-concept (PoC) funding to four scientific teams developing breakthrough technologies aimed at solving global challenges in food security and environmental sustainability.
-
Safeguarding Citrus: International Collaboration Between Australia And Indonesia, Targets Huánglóngbìng Threat6/25/2025
NSW Department of Primary Industries and Regional Development (NSW DPIRD) has reaffirmed its commitment to protecting Australia’s citrus industry through international collaboration against huánglóngbìng (HLB), also known as citrus greening disease.
-
Higgins, Timmons Introduce Legislation To Repeal EPA Rule On Chemical Manufacturing3/11/2025
Congressman Clay Higgins (R-LA) and Congressman William Timmons (R-SC) introduced legislation to repeal the U.S. Environmental Protection Agency’s (EPA) final procedural rule for new chemical reviews under the Toxic Substances Control Act (TSCA).